| Melcher, Rebecca (Bex-Biotec 201803 Managing Director + Founder) |
Managing Director |
Bex-Biotec (Group) |
Germany |
| Meldrum, Eric (Enyo Pharma 201711 CSO) |
Chief Scientific Officer (CSO) / Chief Development Officer (CDO) |
Enyo Pharma S.A. |
France |
| Meldrum, Peter (Myriad 200511 CEO) |
Chief Executive Officer (CEO) |
Myriad Genetics (Group) |
United States (USA) |
| Melerzanov, Alexander (MIPT 201303 Dean of Dept of Molecular + Biological Physics) |
Professor |
Moscow Institute of Physics and Technology (MIPT) |
Russian Federation |
| Melin, Jessica (Sony 201112 Sr Manager Business Development + Sales North America at Sony DADC) |
Business Development Manager / Strategy Manager |
Sony (Group) |
Austria |
| Melingo, Michael (George James 20803– Managing Partner at George James GmbH before Sartorius 201404–201709 + Metrohm) |
Managing Partner |
George James (Group) |
Germany |
| Melnik, Ted (Sumitomo 201503 EVP + COO of Valent BioSciences Corp) |
Chief Operating Officer (COO) |
Sumitomo (Group) |
United States (USA) |
| Melzer, Philipp (CMS Hasche Sigle 201511) |
Attorney / Lawyer |
CMS (Group) |
Germany |
| Meng, Zhang (Tencent 201901 VP of Tencent Medical) |
President/Director/Head Business Group/Unit/Division |
Tencent (00700.HK) |
China |
| Menichella, Daniel L. (Dan) (CureVac 201806– CEO joined 201705 as CEO CureVac Inc before Bamboo Therapeutics) |
Chief Executive Officer (CEO) |
CureVac (Group) |
Germany |
| Menne, Jan (Phenos GmbH 201201 Managing Director) |
Managing Director |
Phenos GmbH |
Germany |
| Menne, Simone (Boehringer Ingelheim 201609–201712 Managing Director responsible for Finance LEFT 12/17) |
Chief Financial Officer (CFO) |
Boehringer Ingelheim (Group) |
Germany |
| Menne, Tobias (Bayer 201702 Head of Digital Farming) |
President/Director/Head Business Group/Unit/Division |
Bayer (Group) |
Germany |
| Mennenga-Klopp, Erk (Hamamatsu 200810 Head Medical Solutions Dept Hamamatsu Germany) |
n. a. |
Hamamatsu Photonics (Group) |
Germany |
| Mennenöh, Henning (Weitnauer 201104– before MLawGroup + Hogan & Hartson Raue LLP) |
Attorney / Lawyer |
Weitnauer Rechtsanwälte Wirtschaftsprüfer Steuerberater |
Germany |
| Mennerich, Detlev (Boehringer Ingelheim 201604 Investment Manager at BIVF) |
Investment Manager |
Boehringer Ingelheim Venture Fund (BIVF) |
Germany |
| Menschaert, Gerben (BioLizard 201909 Co-Founder) |
Company Founder |
BioLizard N.V. |
Netherlands |
| Menyes, Ulf (Enzymicals 201007 CEO Enzymicals AG) |
Chief Executive Officer (CEO) |
Enzymicals AG |
Germany |
| Menzel, Christoph (Qiagen 200909 Senior Global Product Manager Automated Systems) |
Product Manager (personnel) |
Qiagen (Group) |
Germany |
| Menzel, Rosika (BioRepro GmbH 201101 Managing Director) |
Managing Director |
BioRepro GmbH |
Germany |
| Mercanzini, André (Aleva Neurotherapeutics 201108 CTO) |
Chief Technology/Technical Officer (CTO) |
Aleva Neurotherapeutics S.A. |
Switzerland |
| Mercier, David (Strammer 201704 CEO + Founder) |
Chief Executive Officer (CEO) |
Strammer (Group) |
France |
| Mercier, Ray (Thermo Fisher 201609 VP + General Manager Liquid Handling Consumables) |
President/Director/Head Business Group/Unit/Division |
Thermo Fisher (Group) |
United States (USA) |
| Mercker, Ute (Berlin (govt) 201111 Senior Investment Manager Life Science at IBB Beteiligungsges) |
Investment Manager |
Berlin (govt region) |
Germany |
| Meredith, Ian (Boston Scientific 201703 EVP + Global CMO) |
Chief Medical Officer (CMO) |
Boston Scientific (Group) |
United States (USA) |
| Merget, Oliver (ABB 201006 ABB Automation GmbH Sales Chemical Solutions) |
Sales Manager / Marketing Manager |
ABB (Group) |
Germany |
| Merkel, Dirk (Miltenyi Biotech 201303 Licensing Manager Business Developm + Industrial Services) |
Business Development Manager / Strategy Manager |
Miltenyi Biotec (Group) |
Germany |
| Merkl, Bernd (Lophius 201510– Managing Director (Commercial Development) before Geneart 2005– BusDev Manager) |
Managing Director |
Lophius Biosciences GmbH |
Germany |
| Merkle, Fritz (OHB-System 200902 Executive Board Director) |
Board member, executive |
Fuchs (Group) |
Germany |
| Merlot, Cédric (Drugdesigntech 2007– CEO + Founder before Serono since 2001 + Sanofi-Aventis) |
Chief Executive Officer (CEO) |
Drugdesigntech S.A. |
Switzerland |
| Merry, Garry (Sloning 200904– VP Commercial Operations before Bioneer Inc 200611 President) |
Sales Manager / Marketing Manager |
MorphoSys (Group) |
Germany |
| Mersmann, Sophia (Biotype Diagnostic 201107 Product Manager IVD) |
Product Manager (personnel) |
ZÖRGIEBEL Group (family of Wilhelm Zörgiebel) |
Germany |
| Merten, Christoph (Velabs Therapeutics 201906 CSO + Scientific Founder) |
Chief Scientific Officer (CSO) / Chief Development Officer (CDO) |
Velabs Therapeutics GmbH |
Germany |
| Mertens, Christoph (Berlin Capital Fund 200504 Senior Investment Manager) |
Investment Manager |
Triginta Capital (Group) |
Germany |
| Merz, Benedikt (PANATecs –201105c Managing Director) |
Managing Director |
Zukunftsfonds Heilbronn (Group) |
Germany |
| Mescheder, Axel (Cristal Therapeutics 201811– CEO + CMO before MorphoSys/Lanthio + Medpace + TopoTarget + Medigene) |
Chief Executive Officer (CEO) |
Cristal Delivery B.V. (d/b/a/ Cristal Therapeutics) |
Netherlands |
| Metea, Monica (Cyprotex 201609– Director of US Operations before Smithers Viscient + Covance Labs + WIL Research Labs) |
President/Director/Head Business Group/Unit/Division |
Evotec (Group) |
United States (USA) |
| Metges, Cornelia (Leibniz-Gemeinschaft 201109 FBN Dummerstorf Head Research Dept Ernährungsphysiologie) |
Researcher (university / research institute) |
Leibniz-Gemeinschaft |
Germany |
| Methnani, Fathia (MicroSafe 200507 Managing Director) |
Managing Director |
Eurofins (Group) |
Netherlands |
| Methner, Vilma (Co.don 201405 COO + CSO) |
Chief Operating Officer (COO) |
Co.don (Group) |
Germany |
| Metternich, Rainer (Caprotec 201010– Managing Director / CBO + COO before Merck & Co before Schering before Novartis) |
Managing Director |
Caprotec Bioanalytics GmbH |
Germany |
| Metz, Günther (Santhera 201502– appointed SVP Business Development) |
Business Development Manager / Strategy Manager |
Santhera (Group) |
Switzerland |
| Metzger, Markus |
n. a. |
Vontobel (Group) |
Switzerland |
| Metzger, Rainer (Qiagen 201411 VP Business Development Pharma) |
Business Development Manager / Strategy Manager |
Qiagen (Group) |
Germany |
| Metzger-Boddien, Christoph (AnDiaTec 200810) |
n. a. |
AnDiaTec GmbH & Co. KG |
Germany |
| Metzler-Nolte, Nils (Univ Bochum 201201 Professor) |
Professor |
University of Bochum (Ruhr-Universität Bochum) |
Germany |
| Meulien, Pierre (Innovative Medicines Initiative 201807 Executive Director) |
Public Relations Manager / Investor Relations Manager |
Innovative Medicines Initiative (IMI) |
EU (European Union) |
| Meurer, Guido (BRAIN 201405 Unit Head Strain Development + member of executive committee) |
President/Director/Head Business Group/Unit/Division |
BRAIN (Group) |
Germany |
| Meya, Uwe (Minoryx 201606– CMO before Lupin + Synosia + Roche + Novartis + Knoll + Schering) |
Chief Medical Officer (CMO) |
Minoryx (Group) |
Spain (España) |
| Meyer, Andreas (FGen GmbH 201704 CEO + Co-Founder) |
Chief Executive Officer (CEO) |
FGen GmbH |
Switzerland |
| Meyer, Christian (Niedersachsen (govt) 201407 Minister for Comsumer Protection) |
Minister |
Niedersachsen (govt region) |
Germany |
| Meyer, Dieter (Metronomia Clinical Research GmbH 202001 Managing Director) |
Managing Director |
Metronomia Clinical Research GmbH |
Germany |
| Meyer, Georg |
n. a. |
Eurofins (Group) |
Germany |
| Meyer, Helmut E. (Univ Bochum Professor) |
Professor |
University of Bochum (Ruhr-Universität Bochum) |
Germany |
| Meyer, Markus (Bruker 201109 Ion Trap MS Product Manager before Indivumed) |
Product Manager (personnel) |
Bruker Corporation (Group) |
Germany |
| Meyer, Petra (Sal. Oppenheim 7/03) |
n. a. |
Sal. Oppenheim (Group) |
Germany |
| Meyer, Ron (InfanDx 201703 CEO) |
Chief Executive Officer (CEO) |
InfanDx AG |
Germany |
| Meyer, Udo (Bioserv Analytik und Medizinprodukte GmbH 201111 Managing Director) |
Managing Director |
Bioserv Analytik und Medizinprodukte GmbH |
Germany |
| Meyer, Wolfgang (Analyticon Biotechnologies 201105 CEO) |
Chief Executive Officer (CEO) |
Analyticon Biotechnologies AG |
Germany |
| Meyer-Lüerßen, Dierk (VDGH 200809 Managing Director) |
Managing Director |
VDGH (Verband der Diagnostica-Industrie e. V.) |
Germany |
| Meyer-Pannwitt, Karin (TU Hamburg 201105 TuTech Senior Cluster Manager Biokatalyse2021) |
Cluster Manager |
Technical University Hamburg-Harburg (TUHH) |
Germany |
| Meyer-Plath, Sebastian (Bruker Detection 200812 Executive VP + General Manager) |
Product Manager (personnel) |
Bruker Corporation (Group) |
United States (USA) |
| Meyerdierks, Tanja (SiChem GmbH 200902 Managing Director) |
Managing Director |
Sirius Fine Chemicals SiChem GmbH |
Germany |
| Miadek, Andreas (PAA Laboratories GmbH 201108 Managing Director) |
Managing Director |
General Electric (Group) |
Austria |
| Michel, Bruno |
n. a. |
IBM (Group) |
Switzerland |
| Michel, Jan (3B Pharmaceuticals 201602 Director Finance + Corp Development) |
Chief Financial Officer (CFO) |
3B Pharmaceuticals GmbH (3BP) |
Germany |
| Michel, Martin (Inkef Capital 201710 Senior Advisor) |
Consultant (economic/technology) |
ABP (Stichting Pensioenfonds) (Group) |
Netherlands |
| Michel, Willy (Finox AG 201310 majority shareholder + Board President) |
Board member, non-executive |
Finox AG (Finox Biotech) |
Switzerland |
| Michels, Nicola (New Jersey (govt) 201905 Managing Director of Europe office of Choose New Jersey) |
Managing Director |
New Jersey (govt region) |
Germany |
| Micki, Tania (Tecan 202003– CFO before Sulzer AG + Monsanto + Gate Group + General Mills) |
Chief Financial Officer (CFO) |
Tecan (Group) |
Switzerland |
| Middendorp, Oliver (Numab 201703 CBO + Co-Founder before Esbatech 2004–2010) |
Chief Business Officer (CBO) |
Numab (Group) |
Switzerland |
| Middleman, Matt (LifeSci Public Relations 201712 Founding Partner before Russo Partners LLC 201512) |
Public Relations Manager / Investor Relations Manager |
LifeSci (Group) |
United States (USA) |
| Mielach, Andrew (Tiberend Strategic Advisors 201706 Vice President) |
Public Relations Manager / Investor Relations Manager |
Tiberend Strategic Advisors (NY) |
United States (USA) |
| Mielke, Orell (KeyNeurotek 200607– VP Clinical RnD before Parexel International) |
Research & Development Manager |
KeyNeurotek (Group) |
Germany |
| Miels, Luke (GSK 201701– President Global Pharma before AstraZeneca + Roche + Sanofi-Aventis) |
President/Director/Head Business Group/Unit/Division |
GlaxoSmithKline (GSK) (Group) |
United Kingdom (GB) |
| Miersch, Helfried (AMETEK 201003 SPECTRO Analytical Technischer Vertrieb ICP/XRF) |
n. a. |
AMETEK (Group) |
Germany |
| Mietzsch, Andreas (Biocom 201007 CEO) |
Chief Executive Officer (CEO) |
Biocom (Group) |
Germany |
| Miille, Mike (Bayer 201410 Head of Business Management Biologics at Bayer CropScience before AgraQuest) |
President/Director/Head Business Group/Unit/Division |
Bayer (Group) |
Germany |
| Mikitani, Hiroshi (Mickey) (Raktuen CEO + Founder) |
Chief Executive Officer (CEO) |
Rakuten (Group) |
Japan |
| Milad, John E. (Quanta Fluid Solutions Ltd 201411 CEO) |
Chief Executive Officer (CEO) |
Quanta Fluid Solutions Ltd. |
United Kingdom (GB) |
| Milde, Heiko (Hamburg (govt) 201208 Managing Director of Innovationsstarter Hamburg GmbH) |
Managing Director |
Hamburg (govt region) |
Germany |
| Miles, Brad (BMC Communications 201803) |
Public Relations Manager / Investor Relations Manager |
PNC Financial Services (Group) |
United States (USA) |
| Miles, Nick (Speedel 200301–200802 Director Communications) |
Public Relations Manager / Investor Relations Manager |
Novartis (Group) |
Switzerland |
| Miller, Dwayne (Max Planck 201211– Founding Director of MPI for Structure and Dynamics of Matter) |
President/Director/Head Business Group/Unit/Division |
Max Planck Society for the Advancement of Science |
Germany |
| Miller, Kelly (Thermo Fisher 201806 VP/General Manager Laboratory Analytical Reagents) |
General Manager (management) |
Thermo Fisher (Group) |
United States (USA) |
| Miller, Ken (Thermo Fisher 201111– VP Marketing Life Sciences MS before Agilent Marketing Director LC/MS) |
Sales Manager / Marketing Manager |
Thermo Fisher (Group) |
United States (USA) |
| Miller, Rik (DuPont 201410 President DuPont Crop Protection) |
President/Director/Head Business Group/Unit/Division |
DuPont (Group) |
United States (USA) |
| Miller, Thomas (Siemens Healthcare Workflow 200801 CEO) |
Chief Executive Officer (CEO) |
Siemens (Group) |
Germany |
| Miller, Tom (GreyBird Ventures 201908 Partner + 201908– Board Chairman at GNA Biosolutions) |
Partner (venture partner) |
GreyBird Ventures |
|
| Miller, Walter (Mologen 201604– CFO before Nuvisan Gmbh + Santhera Pharmaceuticals) |
Chief Financial Officer (CFO) |
Mologen (Group) |
Germany |
| Mills, Adrian (Novimmune 201409– CBO before GSK since 2000) |
Chief Business Officer (CBO) |
Novimmune S.A. |
Switzerland |
| Mills, Clare (Univ Manchester 201303 Prof at Allergy + Respiratory Centre) |
Professor |
University of Manchester (UoM) |
United Kingdom (GB) |
| Mills, Roger G. (Addex 201611– CMO before Acadia Pharmaceuticals + Pfizer + Gilead + Abbott + Wellcome) |
Chief Medical Officer (CMO) |
Addex (Group) |
Switzerland |
| Milner, Tom (Ametek 201009 SPECTRO) |
Public Relations Manager / Investor Relations Manager |
AMETEK (Group) |
Germany |
| Miltenyi, Stefan (Miltenyi Biotec 201404 Founder + President) |
President/Director/Head Business Group/Unit/Division |
Miltenyi Biotec (Group) |
Germany |
| Minami, Hiroko (ICN 200810– President) |
n. a. |
International Council of Nurses (ICN) |
Switzerland |
| Minkova, Miroslava (Bruker Corp 201611 Head of Investor Relations) |
Public Relations Manager / Investor Relations Manager |
Bruker Corporation (Group) |
United States (USA) |
| Minotta, Mauricio (Thermo Fisher 201511) |
public relations / investor relations |
Thermo Fisher (Group) |
United States (USA) |
| Mintun, Mark (Lilly 201812 VP Neurodegeration + Pain Research) |
Research & Development Manager |
Eli Lilly (Group) |
United States (USA) |
| Mirovsky, Pavel (PharmaSwiss 201102 CEO) |
Chief Executive Officer (CEO) |
Valeant (Group) |
Switzerland |
![[LSG] Life-Sciences-Germany.com - The Life Sciences Web Portal for German-speaking Europe](/images/basics/lsg-life-sciences-germany-portal-logo-2019.png){kind=logo}
![Picture [LSE] Life-Sciences-Europe.com – The Business Web Portal 650x65px](/banner/iito-20181119-650-065-lse-life-sciences-europe-com.jpg)
1 2 3 ... 39 40 41 ... 68 69 70 
![Picture [LSUS] Life-Sciences-USA.com – The Business Web Portal 650x65px](/banner/iito-20181119-650-065-lsus-life-sciences-usa-com.jpg)
![Picture [iito] LSE iitoLifeScience Life Sciences Mass Spec 120x120px](/banner/iito-business-intelligence-20111029-120-120-twitter-iitolifescience-germany-europe-mass-spec.jpg)
![Picture [LSUS] Life-Sciences-USA.com – The Business Web Portal 120x600px](/banner/iito-20181119-120-600-lsus-life-sciences-usa-com.jpg)
